-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 18, China Biosciences announced that recently, after a demonstration organized by the relevant departments of the Joint Prevention and Control Mechanism of the State Council, the Wuhan Institute of Biological Products of Sinopharm Group China Biotech Co.
The 3-17-year-old age group of the new crown vaccine of the Wuhan Institute of Biological Products of China has completed phase I/II clinical trials under the auspices of the Henan Provincial Center for Disease Control and Prevention
After the new crown inactivated vaccine of Wuhan Institute of Biological Products of China Biology was approved for conditional marketing on February 25, 2021, clinical trials for the 3-17 year-old population continued.
The New Crown Inactivated Vaccine from Wuhan Institute of Biological Products of China National Biotechnology Co.